{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:27Z","timestamp":1777984347255,"version":"3.51.4"},"update-to":[{"DOI":"10.12688\/wellcomeopenres.22701.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000}},{"DOI":"10.12688\/wellcomeopenres.22701.2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000}}],"reference-count":27,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["103994"],"award-info":[{"award-number":["103994"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wellcomeopenresearch.org"],"crossmark-restriction":false},"short-container-title":["Wellcome Open Res"],"abstract":"<ns3:p>Background Rates of cardiovascular diseases are increasing annually, and glucose metabolism disorders play an important role in cardiovascular risk. This study aimed to assess changes in cardiovascular risk over time according to the levels of blood glucose, especially prediabetes and type 2 diabetes. Methods Prospective cohort study conducted in the northern Peru. Two were the outcomes of interest, evaluated at the cohort\u2019s baseline and six years after: cardiovascular risk (in percentage), defined using the laboratory-free risk score (HEARTS from the World Health Organization), and the mean arterial pressure (in mmHg); whereas the exposure was the glucose metabolism disorder at cohort\u2019s baseline, especially prediabetes and type 2 diabetes, compared to normoglycaemia. Associations were evaluated using mixed linear regression models, and coefficients (\u03b2) and 95% confidence intervals (95% CI) were reported. Results A total of 1607 subjects were recruited, with a mean age of 48.0 (standard deviation [SD]: 10.5) years, and 50.3% women. Baseline prevalence of prediabetes and type 2 diabetes was 16.9% (95%CI: 15.1%-18.9%) and 11.0% (95%CI: 9.5%-12.6%), respectively; whereas the average of the cardiovascular risk and mean arterial pressure was 3.0% (SD: 2.5%) and 93.1 (SD: 11.9) mmHg, respectively. At baseline, those with prediabetes and type 2 diabetes had a higher cardiovascular risk (0.31% and 0.33%, respectively) and a higher mean arterial pressure (3.3 and 4.2 mmHg, respectively) than those with normal glycaemia. No significant change was found in cardiovascular risk between baseline and follow-up; however, there was a reduction in mean arterial pressure levels, greater among those with normoglycaemia than in cases of prediabetes and type 2 diabetes. Conclusions Glucose metabolism disorders were associated with an increased cardiovascular risk and mean arterial pressure at baseline, but only with higher levels of mean arterial pressure at follow-up. These findings suggest the need for cardiovascular risk assessment in patients with prediabetes and type 2 diabetes.<\/ns3:p>","DOI":"10.12688\/wellcomeopenres.22701.3","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:39:08Z","timestamp":1773059948000},"page":"442","update-policy":"https:\/\/doi.org\/10.12688\/wellcomeopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucose metabolism disorders and changes in cardiovascular risk among adult Peruvian population"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8107-502X","authenticated-orcid":false,"given":"Jhohann","family":"Sedano-Espinoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2660-201X","authenticated-orcid":false,"given":"Kevin","family":"Perez-Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Yalico-Quispe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-1376","authenticated-orcid":false,"given":"Antonio","family":"Bernabe-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2100-32","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease study 2021.","volume":"403","year":"2024","journal-title":"Lancet."},{"key":"ref2","article-title":"The top 10 causes of death.","year":"2020","journal-title":"Geneva, Switzerland: WHO"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"11-28","DOI":"10.1016\/s1098-3597(07)80025-1","article-title":"Cardiovascular disease and modifiable cardiometabolic risk factors.","volume":"8","author":"C Cannon","year":"2007","journal-title":"Clin Cornerstone."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e123-e33","DOI":"10.1016\/S2214-109X(19)30484-X","article-title":"Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys.","volume":"8","year":"2020","journal-title":"Lancet Glob Health."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5334\/gh.1130","article-title":"Urbanization, altitude and cardiovascular risk.","volume":"17","author":"A Bernabe-Ortiz","year":"2022","journal-title":"Glob Heart."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2885-901","DOI":"10.1038\/s41591-023-02610-2","article-title":"Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c.","volume":"29","year":"2023","journal-title":"Nat Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"26-36","DOI":"10.17843\/rpmesp.2019.361.4027","article-title":"Type 2 diabetes mellitus in Peru: a systematic review of prevalence and incidence in the general population","volume":"36","author":"R Carrillo-Larco","year":"2019","journal-title":"Rev Peru Med Exp Salud Publica."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e000110","DOI":"10.1136\/bmjdrc-2015-000110","article-title":"Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study.","volume":"3","author":"S Seclen","year":"2015","journal-title":"BMJ Open Diabetes Res Care."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.29392\/joghr.3.e2019077","article-title":"Characterizing distal peripheral neuropathy in type 2 diabetes mellitus in a semi-urban community setting in Peru.","volume":"3","author":"M Iyengar","year":"2019","journal-title":"J Glob Health Rep."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"49-55","DOI":"10.1136\/jech-2015-205988","article-title":"Contribution of modifiable risk factors for hypertension and type-2 diabetes in Peruvian resource-limited settings.","volume":"70","author":"A Bernab\u00e9-Ortiz","year":"2016","journal-title":"J Epidemiol Community Health."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1042-1048","DOI":"10.1093\/ajh\/hpy094","article-title":"Long-Term risk of hypertension in Normoglycemia and prediabetes, and their relation to the change of Glycemic State.","volume":"31","author":"J Jung","year":"2018","journal-title":"Am J Hypertens."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"874-83","DOI":"10.1001\/jamacardio.2019.2499","article-title":"Ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes.","volume":"4","author":"T Wang","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"517-25","DOI":"10.1016\/j.pcd.2018.07.015","article-title":"Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.","volume":"12","author":"A Bernabe-Ortiz","year":"2018","journal-title":"Prim Care Diabetes."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1332-e1345","DOI":"10.1016\/S2214-109X(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.","volume":"7","year":"2019","journal-title":"Lancet Glob Health."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"751-5","DOI":"10.1097\/HJH.0b013e32803fb621","article-title":"How to assess mean blood pressure properly at the brachial artery level.","volume":"25","author":"W Bos","year":"2007","journal-title":"J Hypertens."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S20-S42","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024.","volume":"47","year":"2024","journal-title":"Diabetes Care."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2560-72","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report.","volume":"289","author":"A Chobanian","year":"2003","journal-title":"JAMA."},{"key":"ref24","article-title":"ODK: collect data anywhere.","year":"2020","journal-title":"ODK"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"49-54","DOI":"10.1097\/MBP.0b013e3282cb57b6","article-title":"Validation of the Omron M7 (HEM-780-E) oscillometric blood pressure monitoring device according to the British hypertension society protocol.","volume":"13","author":"A Coleman","year":"2008","journal-title":"Blood Press Monit."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017.","volume":"17","author":"T Einarson","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.","volume":"355","author":"Y Huang","year":"2016","journal-title":"BMJ."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2124-2131","DOI":"10.2337\/dc20-2252","article-title":"Associations of systolic blood pressure and diastolic blood pressure with the Incidence of coronary artery disease or cerebrovascular disease according to glucose status.","volume":"44","author":"M Yamada","year":"2021","journal-title":"Diabetes Care."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"827-33","DOI":"10.1136\/heartjnl-2016-310347","article-title":"Impact of urbanisation and altitude on the incidence of, and risk factors for, hypertension.","volume":"103","author":"A Bernab\u00e9-Ortiz","year":"2017","journal-title":"Heart."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"103-14","DOI":"10.1177\/096228029700600202","article-title":"Regression towards the mean, historically considered.","volume":"6","author":"S Stigler","year":"1997","journal-title":"Stat Methods Med Res."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"107829","DOI":"10.1016\/j.diabres.2019.107829","article-title":"Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: the CRONICAS cohort study.","volume":"163","author":"M Lazo-Porras","year":"2020","journal-title":"Diabetes Res Clin Pract."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.16862191.v2","author":"A Bernabe-Ortiz","year":"2021","journal-title":"Figshare."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.26348926.v1","article-title":"T2DM SCREEN - Questionnaires (baseline abd follow-up).","author":"A Bernabe-Ortiz","year":"2024","journal-title":"figshare."}],"container-title":["Wellcome Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-442\/v3\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-442\/v3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-442\/v3\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:09:12Z","timestamp":1774926552000},"score":1,"resource":{"primary":{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-442\/v3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":27,"URL":"https:\/\/doi.org\/10.12688\/wellcomeopenres.22701.3","relation":{"has-version":[{"id-type":"doi","id":"10.12688\/wellcomeopenres.22701.2","asserted-by":"subject"},{"id-type":"doi","id":"10.12688\/wellcomeopenres.22701.1","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.21956\/wellcomeopenres.28640.r150309","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.28640.r150308","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.28640.r150309","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.28640.r150308","asserted-by":"object"}]},"ISSN":["2398-502X"],"issn-type":[{"value":"2398-502X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"Indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-442\/v3#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/wellcomeopenres.28640.r150308, Paul Anthony Camacho Lopez, FOSCAL Internacional, Bucaramanga, 10 Mar 2026, version 3, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-442\/v3#referee-response-150308","order":0,"name":"referee-response-150308","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/wellcomeopenres.28640.r150309, Ray Ticse, Universidad Peruana Cayetano Heredia Facultad de Medicina, Lima District, Lima Region, 31 Mar 2026, version 3, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/9-442\/v3#referee-response-150309","order":1,"name":"referee-response-150309","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by Wellcome [103994]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}